IntelGenx Technologies Corp. – TSX:IGX.TO

IntelGenx Technologies Corp. stock price today

CAD 0.275
+0.03
+14.58%
Financial Health
0
1
2
3
4
5
6
7
8
9

IntelGenx Technologies Corp. stock price monthly change

+9.09%
month

IntelGenx Technologies Corp. stock price quarterly change

+26.32%
quarter

IntelGenx Technologies Corp. stock price yearly change

+20.00%
year

IntelGenx Technologies Corp. key metrics

Market Cap
 41.91M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -0.06
Revenue
 1.05M
EBITDA
 -8.15M
Income
 -11.03M
Revenue Q/Q
 7.40%
Revenue Y/Y
 20.11%
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 -776.02%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

IntelGenx Technologies Corp. stock price history

IntelGenx Technologies Corp. stock forecast

IntelGenx Technologies Corp. financial statements

Profit Margin

IntelGenx Technologies Corp. (TSX:IGX.TO): Profit margin
Jun 2023 133K -2.86M -2153.38%
Sep 2023 318K -2.75M -867.61%
Dec 2023 426K -1.38M -323.94%
Mar 2024 174K -4.02M -2314.37%
IGX.TO income statement history

IntelGenx Technologies Corp. Financials Estimate

IntelGenx Technologies Corp. (TSX:IGX.TO): Analyst Estimates
2025 49.87M 23.37M 46.87%

  • Analysts Price target

  • Financials & Ratios estimates

Show more

Debt to Assets

IntelGenx Technologies Corp. (TSX:IGX.TO): Debt to assets
Jun 2023 7824000 16.97M 217.01%
Sep 2023 8113000 19.01M 234.43%
Dec 2023 8282000 20.52M 247.87%
Mar 2024 6548000 21.91M 334.67%
IGX.TO balance sheet history

Cash Flow

IntelGenx Technologies Corp. (TSX:IGX.TO): Cash Flow
Jun 2023 -2.31M 552K -9K
Sep 2023 -1.42M 580K 1.97M
Dec 2023 -526K 116K 1.16M
Mar 2024 -2.85M 0 943K
IGX.TO cash flow history

IntelGenx Technologies Corp. other data

Frequently Asked Questions (FAQ)

  • What's the price of IntelGenx Technologies Corp. stock today?

    One share of IntelGenx Technologies Corp. stock can currently be purchased for approximately $0.28.

  • When is IntelGenx Technologies Corp.'s next earnings date?

    Unfortunately, IntelGenx Technologies Corp.'s (IGX.TO) next earnings date is currently unknown.

  • Does IntelGenx Technologies Corp. pay dividends?

    No, IntelGenx Technologies Corp. does not pay dividends.

  • How much money does IntelGenx Technologies Corp. make?

    IntelGenx Technologies Corp. has a market capitalization of 41.91M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 9.37% to 1.04M US dollars.

  • What is IntelGenx Technologies Corp.'s stock symbol?

    IntelGenx Technologies Corp. is traded on the TSX under the ticker symbol "IGX.TO".

  • What is IntelGenx Technologies Corp.'s primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of IntelGenx Technologies Corp.?

    Shares of IntelGenx Technologies Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When IntelGenx Technologies Corp. went public?

    IntelGenx Technologies Corp. is publicly traded company for more then 17 years since IPO on 27 May 2008.

  • What is IntelGenx Technologies Corp.'s official website?

    The official website for IntelGenx Technologies Corp. is intelgenx.com.

  • Where are IntelGenx Technologies Corp.'s headquarters?

    IntelGenx Technologies Corp. is headquartered at 6420 Abrams, Montreal, QC.

  • How can i contact IntelGenx Technologies Corp.?

    IntelGenx Technologies Corp.'s mailing address is 6420 Abrams, Montreal, QC and company can be reached via phone at +51 43 317440.

IntelGenx Technologies Corp. company profile:

IntelGenx Technologies Corp.

intelgenx.com
Exchange:

TSX

Full time employees:

0

Industry:

Biotechnology

Sector:

Healthcare

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.

+51 43 317440
6420 Abrams
Montreal, QC H4S 1Y2

:
ISIN: US45822R1014
: